hdr isap 2019

News December 2012

Worldwide antibacterial multidrug-resistance is increasing dramatically. As the therapeutic options are limited the International Society of Chemotherapy (ISC) in collaboration with the Asia Pacific Society of Clinical Microbiology and Immunology organised a consensus conference as part of the 13th Asia Pacific Congress of Clinical Microbiology and Immunology. A panel of international experts from Europe, the Americas and Asia discussed the issues of therapeutic options for the management of these difficult to treat pathogens.

Johan Mouton and Ursula Theuretzbacher were invited to contribute their expertise in PK/PD to the consensus meeting. An article that summarizes the discussions of this expert panel will be published soon.